Trial
NCT00609154
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Albert Einstein College of Medicine
Collaborators
Merck Sharp & Dohme LLC; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Type 2 Diabetes
Intervention
glucagon like peptide-1
Why stopped
Per source documents the study was terminated well in advance of targeted enrollment. A method for the analysis of insulin and proinsulin samples was never fully developed and validated. Study terminated upon expiration of IRB approval
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-28